Home/Pipeline/Generic Advair Equivalent

Generic Advair Equivalent

Asthma/COPD

Phase 3Active

Key Facts

Indication

Asthma/COPD

Phase

Phase 3

Status

Active

Company

Cipla

About Cipla

Founded in 1935, Cipla has established itself as a pioneering pharmaceutical company committed to improving global health outcomes through affordable medicines. The company operates across multiple therapeutic areas including respiratory, oncology, anti-retroviral, and complex generics, with a particular strength in inhalation products and biosimilars. Cipla's integrated business model spans from API manufacturing to finished formulations, with a growing focus on digital health solutions and specialty products for developed markets.

View full company profile

Therapeutic Areas

Respiratory Oncology HIV/AIDS Cardiology Neurology Dermatology Gastroenterology

Other Asthma/COPD Drugs

Drug	Company	Phase	Status
Symbicort	AstraZeneca	Approved	Commercial
ProAir (albuterol)	Teva Pharmaceutical Industries	Commercial	Marketed
Generic ProAir (Albuterol HFA)	Lupin Limited	Approved	Commercial
Generic Advair (Fluticasone/Salmeterol)	Lupin Limited	Phase 3	Development
Generic Symbicort	Lupin Limited	Development	Active
Albuterol HFA	Cipla	Commercial	Active
GRC 54276	Glenmark Pharmaceuticals	Phase 2	Active